However, malignant melanoma belongs to the most immunogenic tumor, which can evade T cell recognition by down-regulating tumor associated antigens, defects in antigen processing mechanism, and downregulation of MHC molecules caused by β2-microglobulin mutation, leading to immune evasion (Marzagalli et al., 2019). Here, HLA-C is linked to neoplasm.